Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era

Published:2021-07 Issue:3 Volume:73 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

ALBISINNI Simone,MARTINEZ CHANZA Nieves,AOUN Fouad,DIAMAND Romain,MJAESS Georges,AZZO Jean-Michel,ESPERTO Francesco,BELLMUNT Joaquim,ROUMEGUÈRE Thierry,DE NUNZIO Cosimo

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2021N03A0292

Reference33 articles.

1. En-bloc resection of bladder tumors for pathological staging: the value of lateral margins analysis

2. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

3. The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology

4. Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study

5. Bladder Cancer: New Insights into Its Molecular Pathology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database;Urologic Oncology: Seminars and Original Investigations;2024-03

2. Wolf in sheep's clothing or not? The pT1 LG dilemma;Minerva Urology and Nephrology;2023-12

3. Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy;Biomedicine & Pharmacotherapy;2023-11

4. Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management;Cancer Pathogenesis and Therapy;2023-11

5. Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer;iScience;2023-10